|

ADU-1805 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Sairopa B.V.1

Indications

  • RCC, Clear Cell Adenocarcinoma1
  • Refractory Cancer1
  • CRC (Colorectal Cancer)1
  • NSCLC (Advanced Non-small Cell Lung Cancer)1
  • Metastatic Solid Tumor1

Detroit, Michigan1 trial

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Henry Ford Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.